Grey Literature Search
Grey literature comprises documents and data not published through conventional commercial channels—including theses, government reports, clinical trial registries, conference abstracts, organizational policy documents, and working papers. Unlike journal articles, grey literature is not indexed in MEDLINE or Scopus and often lacks peer review. However, it is crucial for systematic reviews because it may contain null or negative findings that are less likely to be published (publication bias). Systematic grey literature searching is now a standard component of evidence synthesis and is recommended by the Cochrane Collaboration, PRISMA, and other methodological guidelines.
出典記録
引用は手法の出典記録からそのままコピーされています。それらからレベルごとの検証は推論されません。
- Rothstein, H. R., & Hopewell, S. (2009). Grey literature. In J. P. Higgins & S. Green (Eds.), Cochrane handbook for systematic reviews of interventions (Version 5.0.2, Chapter 13). The Cochrane Collaboration. · URL
- Wood, A. M., Egger, M., Gluud, L. L., Schulz, K. F., Jüni, P., Altman, D. G., & Gluud, C. (2008). Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ, 336(7644), 601–605. · DOI 10.1136/bmj.39465.451748.AD
- Mahood, Q., Van Eerd, D., & Irvin, E. (2014). Searching for grey literature for systematic reviews: challenges and benefits. Research Synthesis Methods, 5(4), 353–364. · DOI 10.1002/jrsm.1106
キュレーションされた主張
主張は証拠台帳に永続化され、それぞれが独自の評価を持っています。
このビューは、台帳に主張評価がない場合、主張評価を生成しません。
関連手法
手法グラフから生成され、機械が提案した関係として表示されます — 証拠主張は推論されません。